Information  X 
Enter a valid email address

Societe Generale SA (IRSH)

  Print      Mail a friend

Tuesday 23 February, 2021

Societe Generale SA

Form 8.3 - Willis Towers Watson plc

RNS Number : 0263Q
Societe Generale SA
23 February 2021
 

Ap19

 

 

FORM   8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.  KEY   INFORMATION

 

Nameofpersondealing (Note 1)

Société Générale S.A.

Companydealtin

  Willis Towers Watson plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)

US$0.000304635 ordinary shares

Date of dealing

22/02/2021

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)

 

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

796,086

0.62

1,589

0.00

(2) Derivatives (other than options)

1,428

0.00

8,131

0.01

(3) Options and agreements to purchase/sell

0

0.00

0

0.00

Total

*2,430,970

*1.89

9,720

0.01

 

* Include the holding of shares 1,633,456 on borrow products

 

 

(b)  Interests and short positions in relevant securities of the company, other than the class dealt in  (Note   3)

 

Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

 

 

 

 

(2) Derivatives (other than options)

 

 

 

 

(3) Options and agreements to purchase/sell

 

 

 

 

Total

 

 

 

 

 

 

Ap20

 

 

1.  DEALINGS  (Note   4)

 

(a)  Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit USD (Note 5)

Purchase

100

225.27

Purchase

100

225.88

Purchase

11

225.14

Purchase

100

224.89

Purchase

100

224.79

Purchase

100

224.96

Purchase

267

224.9

Purchase

100

225.07

Purchase

1

224.94

Purchase

99

224.94

Purchase

100

224.78

Purchase

9

225.02

Purchase

91

225.02

Purchase

57

224.68

Purchase

23

224.68

Purchase

20

224.68

Purchase

1

224.95

Purchase

1

224.95

Purchase

100

224.9

Purchase

1,520

224.9

Sale

113,991

224.9

Sale

1

224.998

Sale

1

224.998

Sale

2

225.798

Sale

2

225.248

Sale

2

224.858

Sale

2

224.858

Sale

1

224.748

Sale

2

224.718

Sale

2

225.118

Sale

2

225.388

Sale

2

225.728

Sale

2

224.958

Sale

2

224.818

Sale

1

225.008

Sale

2

225.288

Sale

2

224.928

Sale

2

225.238

Sale

2

225.368

Sale

2

224.838

Sale

2

225.218

Sale

3

224.778

Sale

2

225.758

Sale

2

225.208

Sale

2

224.998

Sale

2

224.678

Sale

2

225.148

Sale

2

224.908

Sale

2

225.288

Sale

2

225.418

Sale

2

225.658

Sale

2

224.958

Sale

1

224.958

Sale

2

224.808

Sale

2

225.318

Sale

2

224.858

Sale

2

225.168

Sale

2

225.208

Sale

2

224.998

Sale

2

224.918

Sale

2

225.518

Sale

2

224.858

Sale

2

225.218

Sale

2

225.718

Sale

1

225.328

Sale

2

225.688

Sale

2

225.058

Sale

2

225.508

Sale

2

224.998

Sale

2

225.108

Sale

2

224.948

Sale

2

225.348

Sale

2

225.268

Sale

2

224.968

Sale

2

224.598

Sale

2

225.328

Sale

3

224.398

Sale

2

224.658

Sale

1

225.048

Sale

2

225.388

Sale

2

224.718

Sale

2

225.298

Sale

2

224.798

Sale

2

225.008

Sale

1

225.018

Sale

2

224.808

Sale

2

224.758

Sale

2

225.268

Sale

2

225.238

Sale

2

225.998

Sale

3

225.248

Sale

2

225.288

Sale

2

225.798

Sale

2

224.958

Sale

2

224.958

Sale

2

225.498

Sale

2

224.998

Sale

1

224.708

Sale

1

225.008

Sale

2

225.218

Sale

1

225.208

Sale

1

224.708

Sale

2

225.088

Sale

2

225.028

Sale

2

225.208

Sale

2

225.248

Sale

2

225.158

Sale

2

225.348

Sale

2

225.198

Sale

2

224.978

Sale

2

225.048

Sale

2

224.858

Sale

2

225.058

Sale

2

225.098

Sale

2

225.778

Sale

2

225.368

Sale

100

224.9

Total Purchases

2,900

 

Total Sales

114,272

 

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 6)

Numberofrelevantsecurities

(Note 7)

Priceperunit USD

(Note 5)

Euro Medium Term Note

Increased long

10

224.90

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing, selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 5)

 

 

 

 

 

 

 

 

 

(ii)  Exercising

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 5)

 

 

 

 

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the 

voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition 

or   disposal   of   any  relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached?  (Note   9)     No

 

Dateofdisclosure

23/02/2021

Contact name

Société Générale - Disclosure team

Telephone number

+33 1 42 14 92 74

If aconnectedEFM,nameofofferee/offerorwithwhichconnected

 

If aconnectedEFM,statenatureofconnection (Note 10)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEKXLBLFLLLBBX

a d v e r t i s e m e n t